Life sciences industry strives towards unified clinical model

The growing number of clinical trials1 and increasing complexity across the clinical lifecycle are putting pressure on life sciences organizations to improve study quality and execution, writes Rik Van Mol, vice president of R&D strategy, Europe, Veeva Systems, in an Expert View piece.

Across the industry, there is growing recognition of the need for a unified clinical model, according to the Veeva 2017 Unified Clinical Operations Survey.

The survey analyses the industry’s progress in its move to improve clinical operations. And the findings, drawn from feedback from 300 clinical operations professionals worldwide, reveal almost universal agreement that organizations need to unify their clinical applications in order to speed study execution, improve study quality, ease collaboration, and achieve greater visibility.